{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:52:36Z","timestamp":1790419956977,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.mayocp.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T05:18:56Z","timestamp":1457673536000},"page":"640-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Opioid Use in Fibromyalgia"],"prefix":"10.1016","volume":"91","author":[{"given":"Don L.","family":"Goldenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Clauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy E.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mayocp.2016.02.002_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3899\/jrheum.090781","article-title":"Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia","volume":"37","author":"Wolfe","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.02.002_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/AJP.0b013e3181cf599f","article-title":"Clinical and economic characteristics of patients with fibromyalgia syndrome","volume":"26","author":"Lachaine","year":"2010","journal-title":"Clin J Pain"},{"issue":"15","key":"10.1016\/j.mayocp.2016.02.002_bib4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mayocp.2016.02.002_bib5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semarthrit.2008.12.003","article-title":"Prevalence of fibromyalgia: a survey in five European countries","volume":"39","author":"Branco","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mayocp.2016.02.002_bib6","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","article-title":"Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project","volume":"65","author":"Vincent","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.mayocp.2016.02.002_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.mayocp.2016.02.002_bib8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.mayocp.2015.03.014","article-title":"Fibromyalgia and related conditions","volume":"90","author":"Clauw","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar4441","article-title":"Review of pharmacological therapies in fibromyalgia syndrome","volume":"16","author":"Hauser","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1756-185X.2010.01567.x","article-title":"The use of opioids in fibromyalgia","volume":"14","author":"Ngian","year":"2011","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2016.02.002_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/RHU.0b013e3182863447","article-title":"Chronic opioid use in fibromyalgia syndrome: a clinical review","volume":"19","author":"Painter","year":"2013","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.mayocp.2016.02.002_bib12","first-page":"113","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J\u00a0Pain"},{"issue":"14","key":"10.1016\/j.mayocp.2016.02.002_bib13","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.0000000000000839","article-title":"Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology","volume":"83","author":"Franklin","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mayocp.2016.02.002_bib14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/ard.2007.071522","article-title":"EULAR evidence-based recommendations for the management of fibromyalgia syndrome","volume":"67","author":"Carville","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2016.02.002_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Res Manag"},{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/bja\/aet351","article-title":"Chronic widespread pain, including fibromyalgia: a pathway for care developed by the British Pain Society","volume":"112","author":"Lee","year":"2014","journal-title":"Br J Anaesth"},{"issue":"7","key":"10.1016\/j.mayocp.2016.02.002_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","article-title":"Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study","volume":"114","author":"Bennett","year":"2003","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib18","first-page":"13","article-title":"Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo","volume":"18","author":"Biasi","year":"1998","journal-title":"Int J Clin Pharmacol Res"},{"issue":"5","key":"10.1016\/j.mayocp.2016.02.002_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00124743-200010000-00004","article-title":"Efficacy of tramadol in treatment of pain in fibromyalgia","volume":"6","author":"Russell","year":"2000","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.02.002_bib20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/ar1971","article-title":"Biology and therapy of fibromyalgia: new therapies in fibromyalgia","volume":"8","author":"Arnold","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2125.1996.tb00152.x","article-title":"Contribution of monoaminergic modulation to the analgesic effect of tramadol","volume":"41","author":"Desmeules","year":"1996","journal-title":"Br J Clin Pharmacol"},{"issue":"166","key":"10.1016\/j.mayocp.2016.02.002_bib22","first-page":"1","article-title":"Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011","author":"Chen","year":"2014","journal-title":"NCHS Data Brief"},{"issue":"4","key":"10.1016\/j.mayocp.2016.02.002_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00002508-200207000-00008","article-title":"Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report","volume":"18","author":"Panerai","year":"2002","journal-title":"Clin J Pain"},{"issue":"7","key":"10.1016\/j.mayocp.2016.02.002_bib24","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/art.22735","article-title":"Up-regulation of delta-opioid receptors and kappa-opioid receptors in the skin of fibromyalgia patients","volume":"56","author":"Salemi","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.mayocp.2016.02.002_bib25","first-page":"1804","article-title":"Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome)","volume":"15","author":"Vaeroy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.mayocp.2016.02.002_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3959(91)90068-9","article-title":"No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg6-Phe7","volume":"46","author":"Vaeroy","year":"1991","journal-title":"Pain"},{"key":"10.1016\/j.mayocp.2016.02.002_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2474-5-48","article-title":"Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain","volume":"5","author":"Baraniuk","year":"2004","journal-title":"BMC Musculoskelet Disord"},{"issue":"37","key":"10.1016\/j.mayocp.2016.02.002_bib28","doi-asserted-by":"crossref","first-page":"10000","DOI":"10.1523\/JNEUROSCI.2849-07.2007","article-title":"Decreased central mu-opioid receptor availability in fibromyalgia","volume":"27","author":"Harris","year":"2007","journal-title":"J\u00a0Neurosci"},{"issue":"4","key":"10.1016\/j.mayocp.2016.02.002_bib29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1526-4637.2009.00613.x","article-title":"Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study","volume":"10","author":"Younger","year":"2009","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.mayocp.2016.02.002_bib30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.37734","article-title":"Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels","volume":"65","author":"Younger","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mayocp.2016.02.002_bib31","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/ALN.0b013e3182a8eb1f","article-title":"Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplasty: a prospective, observational cohort study","volume":"119","author":"Brummett","year":"2013","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.mayocp.2016.02.002_bib32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/ALN.0000000000000637","article-title":"Fibromyalgia survey criteria is associated with increased postoperative opioid consumption in women undergoing hysterectomy","volume":"122","author":"Janda","year":"2015","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/AAP.0000000000000024","article-title":"Characteristics of chronic pain patients who take opioids and persistently report high pain intensity","volume":"39","author":"Wasserman","year":"2014","journal-title":"Reg Anesth Pain Med"},{"issue":"4","key":"10.1016\/j.mayocp.2016.02.002_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13181-012-0260-0","article-title":"Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia","volume":"8","author":"Brush","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"issue":"3 suppl","key":"10.1016\/j.mayocp.2016.02.002_bib35","doi-asserted-by":"crossref","first-page":"ES93","DOI":"10.36076\/ppj.2012\/15\/ES93","article-title":"Opioids and neuropathic pain","volume":"15","author":"Smith","year":"2012","journal-title":"Pain Physician"},{"issue":"3","key":"10.1016\/j.mayocp.2016.02.002_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000542-200603000-00025","article-title":"Opioid-induced hyperalgesia: a qualitative systematic review","volume":"104","author":"Angst","year":"2006","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.mayocp.2016.02.002_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","article-title":"A\u00a0comprehensive review of opioid-induced hyperalgesia","volume":"14","author":"Lee","year":"2011","journal-title":"Pain Physician"},{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib38","first-page":"43","article-title":"Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study","volume":"7","author":"Chu","year":"2006","journal-title":"J\u00a0Pain"},{"issue":"3","key":"10.1016\/j.mayocp.2016.02.002_bib39","first-page":"316","article-title":"Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients","volume":"10","author":"Hay","year":"2009","journal-title":"J\u00a0Pain"},{"issue":"5","key":"10.1016\/j.mayocp.2016.02.002_bib40","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1526-4637.2009.00653.x","article-title":"Do opioids induce hyperalgesia in humans? an evidence-based structured review","volume":"10","author":"Fishbain","year":"2009","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.mayocp.2016.02.002_bib41","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/03009749509095181","article-title":"Pain analysis in patients with fibromyalgia: effects of intravenous morphine, lidocaine, and ketamine","volume":"24","author":"Sorensen","year":"1995","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"10.1016\/j.mayocp.2016.02.002_bib42","first-page":"1615","article-title":"Fibromyalgia: are there different mechanisms in the processing of pain? a double blind crossover comparison of analgesic drugs","volume":"24","author":"Sorensen","year":"1997","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.mayocp.2016.02.002_bib43","first-page":"CD010692","article-title":"Oxycodone for neuropathic pain and fibromyalgia in adults","volume":"6","author":"Gaskell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.mayocp.2016.02.002_bib44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health pathways to prevention workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.mayocp.2016.02.002_bib45","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1742-1241.2007.01480.x","article-title":"Characteristics and healthcare costs of patients with fibromyalgia syndrome","volume":"61","author":"Berger","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"9","key":"10.1016\/j.mayocp.2016.02.002_bib46","first-page":"976","article-title":"Comparison of health care use and costs in newly diagnosed and established patients with fibromyalgia","volume":"10","author":"White","year":"2009","journal-title":"J\u00a0Pain"},{"issue":"5 suppl","key":"10.1016\/j.mayocp.2016.02.002_bib47","first-page":"S118","article-title":"Financial and clinical characteristics of fibromyalgia: a case-control comparison","volume":"16","author":"Palacio","year":"2010","journal-title":"Am J Manag Care"},{"issue":"5 suppl","key":"10.1016\/j.mayocp.2016.02.002_bib48","first-page":"S126","article-title":"Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia","volume":"16","author":"Berger","year":"2010","journal-title":"Am J Manag Care"},{"issue":"3","key":"10.1016\/j.mayocp.2016.02.002_bib49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clinthera.2013.02.003","article-title":"Geographic variation of chronic opioid use in fibromyalgia","volume":"35","author":"Painter","year":"2013","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.mayocp.2016.02.002_bib50","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/acr.22071","article-title":"Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalin","volume":"65","author":"Kim","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.mayocp.2016.02.002_bib51","article-title":"Evaluating guideline-recommended pain medication use among patients with newly diagnosed fibromyalgia","author":"Halpern","year":"2015","journal-title":"Pain Pract"},{"issue":"9","key":"10.1016\/j.mayocp.2016.02.002_bib52","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/art.1780400904","article-title":"A\u00a0prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia","volume":"40","author":"Wolfe","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mayocp.2016.02.002_bib53","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/j.1532-2149.2012.00234.x","article-title":"Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia","volume":"17","author":"Wolfe","year":"2013","journal-title":"Eur J Pain"},{"issue":"10","key":"10.1016\/j.mayocp.2016.02.002_bib54","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1526-4637.2012.01475.x","article-title":"Burden of illness and treatment patterns for patients with fibromyalgia","volume":"13","author":"Robinson","year":"2012","journal-title":"Pain Med"},{"issue":"9","key":"10.1016\/j.mayocp.2016.02.002_bib55","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/pme.12168","article-title":"Longitudinal observation of treatment patterns and outcomes for patients with fibromyalgia: 12-month findings from the reflections study","volume":"14","author":"Robinson","year":"2013","journal-title":"Pain Med"},{"key":"10.1016\/j.mayocp.2016.02.002_bib56","first-page":"898493","article-title":"Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study","volume":"2013","author":"Fitzcharles","year":"2013","journal-title":"Pain Res Treat"},{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/AJP.0000000000000079","article-title":"Long-term evaluation of opioid treatment in fibromyalgia","volume":"31","author":"Peng","year":"2015","journal-title":"Clin J Pain"},{"issue":"10","key":"10.1016\/j.mayocp.2016.02.002_bib58","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.amjmed.2011.05.031","article-title":"Opioid use, misuse, and abuse in patients labeled as fibromyalgia","volume":"124","author":"Fitzcharles","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.mayocp.2016.02.002_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.mayocp.2016.02.002_bib60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2474-13-74","article-title":"The German fibromyalgia consumer reports: a cross-sectional survey","volume":"13","author":"Hauser","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"issue":"S10","key":"10.1016\/j.mayocp.2016.02.002_bib61","first-page":"S491","article-title":"Fibromyalgia patients taking opioids have low self-efficacy and high pain catastrophizing but no reduction in pain or improvement in activity","volume":"66","author":"Adu","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.mayocp.2016.02.002_bib62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1185\/03007995.2011.553214","article-title":"Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States","volume":"27","author":"McNett","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40122-013-0011-1","article-title":"Interpreting effect sizes and clinical relevance of pharmacological interventions for fibromyalgia","volume":"2","author":"Arnold","year":"2013","journal-title":"Pain Ther"},{"issue":"5","key":"10.1016\/j.mayocp.2016.02.002_bib64","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/art.39051","article-title":"Characteristics of fibromyalgia independently predict poorer long-term analgesic outcomes following total knee and hip arthroplasty","volume":"67","author":"Brummett","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"26","key":"10.1016\/j.mayocp.2016.02.002_bib65","first-page":"563","article-title":"Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines: United States, 2012","volume":"63","author":"Paulozzi","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.mayocp.2016.02.002_bib66","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/pme.12107","article-title":"Core competencies for pain management: results of an interprofessional consensus summit","volume":"14","author":"Fishman","year":"2013","journal-title":"Pain Med"},{"key":"10.1016\/j.mayocp.2016.02.002_bib67","series-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","year":"2011"},{"issue":"12","key":"10.1016\/j.mayocp.2016.02.002_bib68","first-page":"1199","article-title":"Pain education in North American medical schools","volume":"12","author":"Mezei","year":"2011","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.mayocp.2016.02.002_bib69","first-page":"791","article-title":"Mitigating the risk of opioid abuse through a balanced undergraduate pain medicine curriculum","volume":"6","author":"Morley-Forster","year":"2013","journal-title":"J\u00a0Pain Res"},{"issue":"1","key":"10.1016\/j.mayocp.2016.02.002_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pmn.2009.10.003","article-title":"Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders","volume":"12","author":"Kindler","year":"2011","journal-title":"Pain Manag Nurs"},{"issue":"7","key":"10.1016\/j.mayocp.2016.02.002_bib71","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.mayocp.2015.04.010","article-title":"Opioid analgesics","volume":"90","author":"Jamison","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.mayocp.2016.02.002_bib72","first-page":"844","article-title":"Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain","volume":"16","author":"Goesling","year":"2015","journal-title":"J\u00a0Pain"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619616001026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619616001026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T23:23:53Z","timestamp":1655249033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619616001026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0025619616001026"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2016.02.002","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid Use in Fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}